Furthermore, in an obesity-related non-alcoholic fatty liver disease (NAFLD) model using obese rats fed with a high-fat diet (HFD), OA restored intestinal barrier function disrupted by the diet and inhibited endotoxin-mediated Toll-like receptor 4-related pathways. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatotic liver disease.